Aspirin Effectiveness and its Influence on Cardiovascular Risk

After watching the webcast you will be automatically forwarded to the evaluation to earn your CME credits.

Speaker Name/Credentials

Jeffrey Boone, M.D.
Founder and Director of the Boone Heart Institute

Estimated Time of Talk

45 minutes

CME Accreditation

45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.00 credits

Description

This webinar will cover clinical implications and therapeutic approaches to patients who are poor responders to aspirin therapy.

Learning Objectives

  1. Learn how aspirin therapy reduces cardiovascular events.
  2. Review how 11-dhTXB2 levels can indicate aspirin effectiveness.
  3. Therapeutic considerations and additional testing for those who are poor responders to aspirin therapy.

Conflicts of Interest

Speaker- Amgen, Aralez, Cleveland HeartLab

This enduring material activity, Aspirin Effectiveness and its Influence on Cardiovascular Risk, has been reviewed and is acceptable for up to 1.00 prescribed credits by the American Academy of Family Physicians. Term of approval begins May 1, 2017. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Share this: